经尿道前列腺切除术后注射a型肉毒杆菌毒素与口服抗胆碱能药物治疗膀胱出口梗阻伴膀胱过度活动的疗效:一项前瞻性随机临床试验研究

IF 1.5 Q3 UROLOGY & NEPHROLOGY American journal of clinical and experimental urology Pub Date : 2023-01-01
Farzad Allameh, Mohammad Hosseininia, Arian Karimi Rouzbahani, Behzad Narouie, Mehdi Dadpour
{"title":"经尿道前列腺切除术后注射a型肉毒杆菌毒素与口服抗胆碱能药物治疗膀胱出口梗阻伴膀胱过度活动的疗效:一项前瞻性随机临床试验研究","authors":"Farzad Allameh,&nbsp;Mohammad Hosseininia,&nbsp;Arian Karimi Rouzbahani,&nbsp;Behzad Narouie,&nbsp;Mehdi Dadpour","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>To compare the effect of botulinum toxin-A (BoNT-A) injection versus oral anticholinergic agents following transurethral resection of the prostate (TURP) in patients with benign prostatic hyperplasia (BPH) and Overactive Bladder.</p><p><strong>Materials and methods: </strong>In this randomized clinical trial from February 2021 till May 2022 data of patients with obstructive urinary symptoms and urgency incontinence were analyzed. The intervention group consisted of 35 patients who were injected with 300 units of BoNT-A (Dysport<sup>®</sup>) into the detrusor muscles at the same time as TURP. 38 participants in the control group were treated with solifenacin 5 mg (Urinacin<sup>®</sup>) daily after TURP.</p><p><strong>Results: </strong>In the evaluation of 73 included patients (mean age: 67.54±6.3), IPSS score change (first month, P=0.777; 6<sup>th</sup> month, P=0.761) and storage irritative symptoms change score (first month, P=0.995; 6<sup>th</sup> month, P=0.962) were decreased and Qmax was increased (first month, P=0.195; 6<sup>th</sup> month, P=0.174) similarly in 2 groups. Lower number of patients experienced urgency incontinence during follow up time in intervention group, significantly (first month, 18 versus 5, P=0.002; 6<sup>th</sup> month, 20 versus 6, P=0.002). PVR was also decreased more in first month and 6<sup>th</sup> month follow up in patients of intervention group (1<sup>th</sup> month, P=0.012; 6<sup>th</sup> month, P=0.033).</p><p><strong>Conclusion: </strong>Anticholinergic agents or intradetrusor BoNT-A injection would improve the storage symptoms in patients with BPH and detrusor overactivity following TURP. In contrast to IPSS score, storage irritative score and Qmax, which improve similarly in both groups, the PVR and urgency incontinence episodes will improve more in patients receive intradetrusor BoNT-A injection.</p>","PeriodicalId":7438,"journal":{"name":"American journal of clinical and experimental urology","volume":null,"pages":null},"PeriodicalIF":1.5000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333132/pdf/ajceu0011-0228.pdf","citationCount":"0","resultStr":"{\"title\":\"Efficacy of botulinum toxin-A injection versus oral anticholinergic medications following transurethral resection of the prostate to manage bladder outlet obstruction with overactive bladder: a prospective randomized clinical trial study.\",\"authors\":\"Farzad Allameh,&nbsp;Mohammad Hosseininia,&nbsp;Arian Karimi Rouzbahani,&nbsp;Behzad Narouie,&nbsp;Mehdi Dadpour\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>To compare the effect of botulinum toxin-A (BoNT-A) injection versus oral anticholinergic agents following transurethral resection of the prostate (TURP) in patients with benign prostatic hyperplasia (BPH) and Overactive Bladder.</p><p><strong>Materials and methods: </strong>In this randomized clinical trial from February 2021 till May 2022 data of patients with obstructive urinary symptoms and urgency incontinence were analyzed. The intervention group consisted of 35 patients who were injected with 300 units of BoNT-A (Dysport<sup>®</sup>) into the detrusor muscles at the same time as TURP. 38 participants in the control group were treated with solifenacin 5 mg (Urinacin<sup>®</sup>) daily after TURP.</p><p><strong>Results: </strong>In the evaluation of 73 included patients (mean age: 67.54±6.3), IPSS score change (first month, P=0.777; 6<sup>th</sup> month, P=0.761) and storage irritative symptoms change score (first month, P=0.995; 6<sup>th</sup> month, P=0.962) were decreased and Qmax was increased (first month, P=0.195; 6<sup>th</sup> month, P=0.174) similarly in 2 groups. Lower number of patients experienced urgency incontinence during follow up time in intervention group, significantly (first month, 18 versus 5, P=0.002; 6<sup>th</sup> month, 20 versus 6, P=0.002). PVR was also decreased more in first month and 6<sup>th</sup> month follow up in patients of intervention group (1<sup>th</sup> month, P=0.012; 6<sup>th</sup> month, P=0.033).</p><p><strong>Conclusion: </strong>Anticholinergic agents or intradetrusor BoNT-A injection would improve the storage symptoms in patients with BPH and detrusor overactivity following TURP. In contrast to IPSS score, storage irritative score and Qmax, which improve similarly in both groups, the PVR and urgency incontinence episodes will improve more in patients receive intradetrusor BoNT-A injection.</p>\",\"PeriodicalId\":7438,\"journal\":{\"name\":\"American journal of clinical and experimental urology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.5000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333132/pdf/ajceu0011-0228.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American journal of clinical and experimental urology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"UROLOGY & NEPHROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of clinical and experimental urology","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:比较经尿道前列腺切除术(TURP)后注射肉毒毒素a (BoNT-A)与口服抗胆碱能药物对良性前列腺增生(BPH)和膀胱过动症患者的疗效。材料与方法:本随机临床试验于2021年2月至2022年5月期间对有梗阻性尿失禁和急迫性尿失禁患者的资料进行分析。干预组由35例患者组成,在TURP的同时向逼尿肌注射300单位BoNT-A (Dysport®)。对照组38例患者在TURP术后每日给予索利那新5mg(尿苷酸®)治疗。结果:入选患者73例(平均年龄:67.54±6.3),IPSS评分变化(第1个月,P=0.777;第6个月,P=0.761)和储存刺激症状变化评分(第1个月,P=0.995;第6个月,P=0.962)下降,Qmax升高(第1个月,P=0.195;第6个月,P=0.174)。干预组在随访期间出现急迫性尿失禁的患者数量明显减少(第1个月,18例对5例,P=0.002;第6个月,20对6,P=0.002)。干预组患者随访第1个月和第6个月PVR下降幅度更大(第1个月,P=0.012;第6个月,P=0.033)。结论:抗胆碱能药物或肌内注射BoNT-A可改善前列腺增生和尿逼肌过度活动患者的储存症状。与IPSS评分、存储刺激评分和Qmax改善相似的两组相比,接受肌内注射BoNT-A的患者PVR和急迫性尿失禁发作改善更多。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Efficacy of botulinum toxin-A injection versus oral anticholinergic medications following transurethral resection of the prostate to manage bladder outlet obstruction with overactive bladder: a prospective randomized clinical trial study.

Background: To compare the effect of botulinum toxin-A (BoNT-A) injection versus oral anticholinergic agents following transurethral resection of the prostate (TURP) in patients with benign prostatic hyperplasia (BPH) and Overactive Bladder.

Materials and methods: In this randomized clinical trial from February 2021 till May 2022 data of patients with obstructive urinary symptoms and urgency incontinence were analyzed. The intervention group consisted of 35 patients who were injected with 300 units of BoNT-A (Dysport®) into the detrusor muscles at the same time as TURP. 38 participants in the control group were treated with solifenacin 5 mg (Urinacin®) daily after TURP.

Results: In the evaluation of 73 included patients (mean age: 67.54±6.3), IPSS score change (first month, P=0.777; 6th month, P=0.761) and storage irritative symptoms change score (first month, P=0.995; 6th month, P=0.962) were decreased and Qmax was increased (first month, P=0.195; 6th month, P=0.174) similarly in 2 groups. Lower number of patients experienced urgency incontinence during follow up time in intervention group, significantly (first month, 18 versus 5, P=0.002; 6th month, 20 versus 6, P=0.002). PVR was also decreased more in first month and 6th month follow up in patients of intervention group (1th month, P=0.012; 6th month, P=0.033).

Conclusion: Anticholinergic agents or intradetrusor BoNT-A injection would improve the storage symptoms in patients with BPH and detrusor overactivity following TURP. In contrast to IPSS score, storage irritative score and Qmax, which improve similarly in both groups, the PVR and urgency incontinence episodes will improve more in patients receive intradetrusor BoNT-A injection.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
8.30%
发文量
0
期刊最新文献
A case series of emphysematous pyelonephritis in COVID-positive patients. Artificial intelligence in pathologic diagnosis, prognosis and prediction of prostate cancer. Identification of ECM and EMT relevant genes involved in the progression of bladder cancer through bioinformatics analysis. Long time follow-up for patients with testicular torsion: new findings. Prognostic significance of the PI-RADS score in men with prostate cancer undergoing radical prostatectomy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1